PL4087543T3 - Polimerowe substancje pomocnicze do stosowania w dziedzinie dostarczania leków według ujawnienia - Google Patents

Polimerowe substancje pomocnicze do stosowania w dziedzinie dostarczania leków według ujawnienia

Info

Publication number
PL4087543T3
PL4087543T3 PL20706864.4T PL20706864T PL4087543T3 PL 4087543 T3 PL4087543 T3 PL 4087543T3 PL 20706864 T PL20706864 T PL 20706864T PL 4087543 T3 PL4087543 T3 PL 4087543T3
Authority
PL
Poland
Prior art keywords
drug delivery
delivery applications
polymer excipients
excipients
polymer
Prior art date
Application number
PL20706864.4T
Other languages
English (en)
Inventor
Kevin N. Sill
Broadford T. SULLIVAN
Original Assignee
Tyndall Formulation Services, LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tyndall Formulation Services, LLC filed Critical Tyndall Formulation Services, LLC
Publication of PL4087543T3 publication Critical patent/PL4087543T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/48Polymers modified by chemical after-treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
PL20706864.4T 2020-01-10 2020-01-10 Polimerowe substancje pomocnicze do stosowania w dziedzinie dostarczania leków według ujawnienia PL4087543T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2020/013166 WO2021141603A1 (en) 2020-01-10 2020-01-10 Polymer excipients for drug delivery applications

Publications (1)

Publication Number Publication Date
PL4087543T3 true PL4087543T3 (pl) 2024-04-29

Family

ID=69650694

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20706864.4T PL4087543T3 (pl) 2020-01-10 2020-01-10 Polimerowe substancje pomocnicze do stosowania w dziedzinie dostarczania leków według ujawnienia

Country Status (13)

Country Link
EP (2) EP4417221A3 (pl)
JP (1) JP2023516855A (pl)
KR (1) KR20220140508A (pl)
CN (1) CN115135694B (pl)
AU (1) AU2020421494A1 (pl)
BR (1) BR112022013519A2 (pl)
CA (1) CA3166918A1 (pl)
CR (1) CR20220373A (pl)
ES (1) ES2975218T3 (pl)
IL (1) IL294481A (pl)
MX (1) MX2022008510A (pl)
PL (1) PL4087543T3 (pl)
WO (1) WO2021141603A1 (pl)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2671772A (en) * 1949-08-12 1954-03-09 Du Pont Alpha-amino acid copolymers
NZ599523A (en) * 2007-04-30 2013-10-25 Intezyne Technologies Inc Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents
US20130296531A1 (en) * 2012-04-11 2013-11-07 Intezyne Technologies, Inc. Block copolymers for stable micelles
WO2014200007A1 (ja) * 2013-06-12 2014-12-18 株式会社 島津製作所 両親媒性ブロックポリマーを用いた分子集合体、及びそれを用いた物質搬送用キャリア

Also Published As

Publication number Publication date
BR112022013519A2 (pt) 2022-09-13
IL294481A (en) 2022-09-01
CN115135694A (zh) 2022-09-30
KR20220140508A (ko) 2022-10-18
JP2023516855A (ja) 2023-04-21
CR20220373A (es) 2022-11-23
CA3166918A1 (en) 2021-07-15
AU2020421494A1 (en) 2022-07-21
ES2975218T3 (es) 2024-07-04
EP4087543C0 (en) 2024-03-06
EP4417221A3 (en) 2024-10-23
CN115135694B (zh) 2024-03-15
MX2022008510A (es) 2022-09-26
WO2021141603A1 (en) 2021-07-15
EP4087543A1 (en) 2022-11-16
EP4087543B1 (en) 2024-03-06
EP4417221A2 (en) 2024-08-21

Similar Documents

Publication Publication Date Title
IL304573A (en) Drug delivery device
EP4088759A4 (en) IMPLANTABLE MANUALLY CONTROLLED DRUG DELIVERY DEVICE
EP4192569A4 (en) DEVICE FOR DELIVERING MEDICATION TO BE INGESTED
EP4049698A4 (en) DRUG DELIVERY DEVICE
CA215995S (en) Drug delivery system
CA215997S (en) Drug delivery system
CA215994S (en) Drug delivery system
PL4087543T3 (pl) Polimerowe substancje pomocnicze do stosowania w dziedzinie dostarczania leków według ujawnienia
EP4096645A4 (en) DRUG DELIVERY DEVICE
GB2611605B (en) Drug delivery device
CA209594S (en) Drug delivery device
GB2611607B (en) Drug delivery device
GB2611606B (en) Drug delivery device
CA231033S (en) Drug delivery device
GB202314518D0 (en) Drug delivery device
EP4209236A4 (en) DRUG DELIVERY DEVICE
KR102391865B9 (ko) 약물 전달 디바이스
GB202213744D0 (en) Drug Delivery Device
AU2021903904A0 (en) Intragenital drug delivery device
AU2020904446A0 (en) Intragenital drug delivery device
AU2020900258A0 (en) Drug delivery device
GB202213668D0 (en) Improved drug delivery systems
SE2450190A1 (en) Drug delivery system
AU2023903947A0 (en) Intragenital drug delivery device
AU2022903702A0 (en) Intragenital drug delivery device